FZD5 and ovarian cancer: Overexpression of FZD5 or ARID3B in ovarian cancer cells increases adhesion to several ECM proteins, including fibronectin and vitronectin, while knockdown of FZD5 or editing of ARID3B causes a loss of adhesion to certain ECM components.